Tonix Pharmaceuticals Holding Corp

Research Tonix Pharmaceuticals Holding Corp (TNXP) on Bullrun: market cap USD 79.60M. Explore financials, valuation history, model signals, and stock context.

Key Metrics

Valuation Snapshot

latest market cap is USD 79.60M.

Five-year financial history

YearRevenueNet incomeFree cash flowGross marginDiluted EPSCashTotal debtEquity
FY2025USD 13.11M-USD 124.02M-USD 103.21M49.3%-14.57USD 207.64MUSD 1.31MUSD 245.15M
FY2024USD 10.09M-USD 130.04M-USD 61.05M23.1%-176.6USD 98.78MUSD 7.49MUSD 139.56M
FY2023USD 7.77M-USD 116.66M-USD 109.90M39.0%-14720.25USD 24.95MUSD 8.91MUSD 105.53M
FY2022USD 0-USD 110.22M-USD 146.20Mn/a-20.01USD 120.23MUSD 760.00KUSD 207.18M

Valuation history

YearSnapshot dateMarket capP/EDividend yieldAnnual dividend/share
20262026-11-06USD 79.60Mn/an/an/a
20252025-12-31USD 114.92Mn/an/an/a
20242024-12-31USD 144.73Mn/an/an/a
20232023-12-29USD 23.42Mn/an/an/a
20222022-12-30USD 22.62Mn/an/an/a
20212021-12-31USD 184.32Mn/an/an/a

About Tonix Pharmaceuticals Holding Corp

Tonix Pharmaceuticals Holding Corp., a fully integrated biopharmaceutical company, develops and commercializes therapies for central nervous system (CNS) disorders, immunology and immuno-oncology, infectious diseases, and rare diseases in the United States. The company offers TONMYA, a cyclobenzaprine HCl sublingual tablet for the treatment of fibromyalgia. It also markets Zembrace SymTouch and Tosymra for the treatment of acute migraine with or without aura in adults.

ETFs that hold Tonix Pharmaceuticals Holding Corp

US-listed ETFs

Tonix Pharmaceuticals Holding Corp is held by 18 US-listed ETFs, going by the latest portfolios they filed with the SEC. The 8 most traded of them:

ETFWeightFee
iShares Russell 2000 ETF (IWM)0.01%0.19%
Vanguard Morningstar Total Stock Market ETF (VTI)<0.01%0.03%
iShares Core S&P Total U.S. Stock Market ETF (ITOT)<0.01%0.03%
Vanguard Russell 2000 Index Fund ETF Shares (VTWO)<0.01%0.06%
iShares Russell 2000 Value ETF (IWN)0.01%0.24%
Vanguard Extended Market Index Fund ETF Shares (VXF)<0.01%0.05%
Fidelity Enhanced Small Cap Core ETF (FESM)0.02%0.28%
U.S. Small Cap Portfolio-ETF Class Shares (DFAS)<0.01%0.26%

Portfolios as filed with the SEC on Form N-PORT, dated May to July 2026. Brokers in the EU generally do not offer US-listed ETFs to retail investors.

Related stock research

Other Healthcare stocks

Frequently asked questions

What is Tonix Pharmaceuticals Holding Corp's market cap?

Tonix Pharmaceuticals Holding Corp's market capitalization is USD 79.60M.

What does Tonix Pharmaceuticals Holding Corp do?

Tonix Pharmaceuticals Holding Corp., a fully integrated biopharmaceutical company, develops and commercializes therapies for central nervous system (CNS) disorders, immunology and immuno-oncology, infectious diseases, and rare diseases in the United States. The company offers TONMYA, a cyclobenzaprine HCl sublingual tablet for the treatment of fibromyalgia. It also markets Zembrace SymTouch and Tosymra for the treatment of acute migraine with or without aura in adults.